Structures by: Stetsiuk O.
Total: 13
2-[(<i>E</i>)-{[3-(1<i>H</i>-Imidazol-1-yl)propyl]imino}methyl]-4-[(<i>E</i>)-(4-methylphenyl)diazenyl]phenol
C20H21N5O
IUCrData (2019) 4, 1 x190036
a=12.2410(4)Å b=5.9386(2)Å c=25.2112(9)Å
α=90° β=90.317(3)° γ=90°
C52H68Cl2Co2Mn4N8O18,2(C3H7NO)
C52H68Cl2Co2Mn4N8O18,2(C3H7NO)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 31 11862-11871
a=8.5730(2)Å b=21.4804(4)Å c=18.9257(4)Å
α=90° β=91.632(2)° γ=90°
C8H7ClN6
C8H7ClN6
Dalton transactions (Cambridge, England : 2003) (2019) 48, 31 11966-11977
a=4.1825(5)Å b=23.824(2)Å c=9.9296(9)Å
α=90° β=97.827(10)° γ=90°
C16H14Cl4CuN12,2(C2H3N)
C16H14Cl4CuN12,2(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 31 11966-11977
a=8.1726(7)Å b=8.7426(7)Å c=10.3892(8)Å
α=82.662(7)° β=67.773(8)° γ=79.566(7)°
C18H9ClCuF12N6O4
C18H9ClCuF12N6O4
Dalton transactions (Cambridge, England : 2003) (2019) 48, 31 11966-11977
a=15.9292(3)Å b=9.21150(10)Å c=17.4056(3)Å
α=90° β=101.765(2)° γ=90°
C16H12Cl3Cu2N12
C16H12Cl3Cu2N12
Dalton transactions (Cambridge, England : 2003) (2019) 48, 31 11966-11977
a=13.5525(3)Å b=11.4392(2)Å c=13.7445(3)Å
α=90° β=104.474(2)° γ=90°
C17H12Cl2Cu2F3N12O3S
C17H12Cl2Cu2F3N12O3S
Dalton transactions (Cambridge, England : 2003) (2019) 48, 31 11966-11977
a=15.3612(4)Å b=10.9054(3)Å c=15.4148(5)Å
α=90° β=111.358(4)° γ=90°
Tetrakis-[2-((2-oxidoethylimino)methyl)phenolate]-tris(methanol)-tricopper(II) manganese(III) Triiodide
C39H48Cu3MnN4O11,I3
Dalton Trans. (2017)
a=13.3737(11)Å b=15.6103(8)Å c=23.0857(18)Å
α=90° β=92.535(9)° γ=90°
Bis-[Tetrakis-[2-((2-oxidoethylimino)methyl)phenolate]-tris(methanol)- tricopper(II) manganese(III)] Tetraisothiocyanatomanganate(II) Dimethanol solvate
2(C39H48Cu3MnN4O11),C4MnN4S4,2(CH4O)
Dalton Trans. (2017)
a=13.5453(4)Å b=15.1781(4)Å c=26.9837(9)Å
α=90.892(2)° β=103.293(2)° γ=114.678(2)°
C39H50Cu3MnN4O12,CNS,(H2O)
C39H50Cu3MnN4O12,CNS,(H2O)
Dalton Trans. (2017)
a=18.5500(12)Å b=12.9260(8)Å c=19.8784(14)Å
α=90° β=98.170(10)° γ=90°
Br,C37H44Cu3MnN4O11,H2O
Br,C37H44Cu3MnN4O11,H2O
Dalton Trans. (2017)
a=17.9628(14)Å b=13.0651(9)Å c=19.7336(14)Å
α=90° β=96.001(7)° γ=90°
C36H36Cu3MnN4O8,4(H2O),BF4
C36H36Cu3MnN4O8,4(H2O),BF4
Dalton Trans. (2017)
a=16.8093(9)Å b=13.6009(7)Å c=19.1235(10)Å
α=90° β=93.479(5)° γ=90°
3,6-Bis(pyridin-2-yl)-4-{[(3a<i>S</i>,5<i>S</i>,5a<i>R</i>,8a<i>R</i>,8b<i>S</i>)-2,2,7,7-tetramethyltetrahydro-5<i>H</i>-bis[1,3]dioxolo[4,5-<i>b</i>:4',5'-<i>d</i>]pyran-5-yl)methoxy]methyl}pyridazine monohydrate
C27H30N4O6,H2O
Acta Crystallographica Section E (2019) 75, 8 1169-1174
a=8.8417(3)Å b=11.3252(3)Å c=25.7003(8)Å
α=90° β=90° γ=90°